Sharps Technology, Inc. (STSS)

US — Healthcare Sector
Peers: ZJYL  MHUA  GMVD  GCTK  LUCY  NXGL  AVGR  MBOT  POCI  KRMD  INFU  UTMD  MLSS 

Automate Your Wheel Strategy on STSS

With Tiblio's Option Bot, you can configure your own wheel strategy including STSS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol STSS
  • Rev/Share 0.0
  • Book/Share 202.9582
  • PB 0.0176
  • Debt/Equity 0.0
  • CurrentRatio 1.6132
  • ROIC -0.8167

 

  • MktCap 3638105.0
  • FreeCF/Share -141.5425
  • PFCF -0.5147
  • PE -0.0279
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.9878

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule
STSS
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from Nasdaq confirming that the Company has regained compliance with The Nasdaq's Capital Market's minimum bid price requirement of $1.00 per share and the minimum stockholders' equity requirement of $2.5 million.

Read More
image for news Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule
Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
STSS
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET. Presentation Details: Presenter: Robert Hayes, CEO Date: May 22, 2025 Time: 1:00 p.m.

Read More
image for news Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025
STSS
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's proposal before the shareholder meeting, which is scheduled to be held on March 28, 2025, at 10:00 a.m. Eastern Time.

Read More
image for news Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025

About Sharps Technology, Inc. (STSS)

  • IPO Date 2022-04-14
  • Website https://sharpstechnology.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Robert M. Hayes
  • Employees 55

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.